Patricia Carr
Chief Accounting Officer
Jazz Pharmaceuticals plc (JAZZ)Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsAbout Patricia Carr
Patricia Carr is recorded as Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ). The newest filing on record that lists Patricia Carr as Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ) is dated June 14, 2024. The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $1,452,210 for Patricia Carr in fiscal 2024, including a base salary of $429,954. Disclosed compensation is on record for 2 fiscal years. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed June 14, 2024
-
Jazz Pharmaceuticals plc (JAZZ)
Proxy statement
Start not stated–2021-06-11
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Jazz Pharmaceuticals plc
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Jazz Pharmaceuticals plc (JAZZ) | Senior Vice President and CAO (Former Interim Principal Financial Officer) | $429,954 | $1,452,210 |
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | Senior Vice President and CAO (Former Interim Principal Financial Officer) | $402,181 | $1,401,028 |
Recent activity
No call appearances or filed executive changes recorded yet.